Satsuma Pharmaceuticals Stock Price To Book
| STSADelisted Stock | USD 1.10 0.01 0.90% |
Satsuma Pharmaceuticals fundamentals help investors to digest information that contributes to Satsuma Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Satsuma Stock. The fundamental analysis module provides a way to measure Satsuma Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Satsuma Pharmaceuticals stock.
Satsuma |
Satsuma Pharmaceuticals Company Price To Book Analysis
Satsuma Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Satsuma Pharmaceuticals Price To Book | 0.42 X |
Most of Satsuma Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satsuma Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Satsuma Pharmaceuticals has a Price To Book of 0.4202 times. This is 98.36% lower than that of the Pharmaceuticals sector and 93.04% lower than that of the Health Care industry. The price to book for all United States stocks is 95.58% higher than that of the company.
Satsuma Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satsuma Pharmaceuticals' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Satsuma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Satsuma Pharmaceuticals by comparing valuation metrics of similar companies.Satsuma Pharmaceuticals is currently under evaluation in price to book category among its peers.
Satsuma Fundamentals
| Return On Equity | -1.04 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | (35.53 M) | |||
| Shares Outstanding | 33.15 M | |||
| Shares Owned By Insiders | 10.43 % | |||
| Shares Owned By Institutions | 57.90 % | |||
| Number Of Shares Shorted | 130.12 K | |||
| Price To Earning | 22.12 X | |||
| Price To Book | 0.42 X | |||
| EBITDA | (58.31 M) | |||
| Net Income | (70.06 M) | |||
| Cash And Equivalents | 68.06 M | |||
| Cash Per Share | 2.15 X | |||
| Total Debt | 205 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 9.18 X | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (51.52 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (1.99) X | |||
| Price To Earnings To Growth | 4.50 X | |||
| Target Price | 2.0 | |||
| Number Of Employees | 25 | |||
| Beta | 0.1 | |||
| Market Capitalization | 36.8 M | |||
| Total Asset | 54.94 M | |||
| Retained Earnings | (211.79 M) | |||
| Working Capital | 46.69 M | |||
| Z Score | 99.83 | |||
| Net Asset | 54.94 M |
About Satsuma Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Satsuma Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Satsuma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Satsuma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |